|
Marker | Population | Country | Oral fluid device or sample collection | Assay | Sensitivity | Specificity | Reference |
|
HBsAg | Local and out-of-state public health clinics | USA | Orasure | Commercial Enzyme immunoassay | 100.0% | 100.0% | [7] |
Anti-HBc IgM | Local and out-of-state public health clinics | USA | Orasure | Commercial Enzyme immunoassay | 100.0% | 100.0% | [7] |
HBsAg | Patients with and without HBV | Thailand | Whole saliva | Commercial Enzyme immunoassay | 96.5% | 100.0% | [8] |
Anti-HBc | Rural community | Ethiopia | Sponge swab | Commercial Enzyme immunoassay | 43.0% | 87.0% | [9] |
Anti-HBc | blood donors and injecting drug users | Denmark | Omni-Sal | Commercial Enzyme immunoassay | 85.9% | 100.0% | [10] |
HBsAg | Unit of Gastroenterology of three university hospitals | Belgium | Oracol | Commercial Enzyme immunoassay | 90.7% | 100.0% | [11] |
Anti-HBc Total | Viral Hepatitis ambulatory | Brazil | Orasure | Commercial Enzyme immunoassay | 13% | 100.0% | [12] |
Anti-HBc IgM | Viral Hepatitis ambulatory | Brazil | Orasure | Commercial Enzyme immunoassay | 100.0% | 100.0% | [12] |
Anti-HBs | Viral Hepatitis ambulatory | Brazil | Orasure | Commercial Enzyme immunoassay | 8.33% | 100.0% | [12] |
HBsAg | Viral Hepatitis ambulatory | Brazil | Salivette | Commercial Enzyme immunoassay | 85.1% | 94.1% | [13] |
Whole saliva | 93.6% | 92.6% |
HBsAg | Viral Hepatitis ambulatory and Pantanal of Mato Grosso do Sul | Brazil | Chembio | Commercial Enzyme immunoassay | 95.2% | 100% | [14] |
78.3% | 89.9% |
Salivette |
HBsAg | Patients with and without HBV | India | Whole saliva | Commercial Enzyme immunoassay | 100% | 100% | [15] |
HBsAg | Alcoholics | Brazil | Salivette | Commercial Enzyme immunoassay | Not available | 100% | [16] |
HBsAg | Viral Hepatitis ambulatory | Brazil | Salivette | Commercial Enzyme immunoassay | 80.9% | 86.8% | [17] |
Anti-HBc | 82.4% | 96.9% |
|